New treatment options for Bartter's syndrome [4]

New England Journal of Medicine

Volumn 343, Issue 9, 2000, Pages 661-662

  Kleta, R ^a   Basoglu, C ^a   Kuwertz Broking, E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN E2; ROFECOXIB;

BARTTER SYNDROME; CASE REPORT; CHILD; FEMALE; HUMAN; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; SALT LOSING NEPHRITIS; SODIUM INTAKE; TREATMENT OUTCOME; URINARY EXCRETION;

BARTTER SYNDROME; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; ISOENZYMES; LACTONES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SODIUM, DIETARY; SULFONES;

EID: 0034739294     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200008313430915     Document Type: Letter

References (5)

1. NaCl transport deficiencies - Hemodynamics to the rescue
2. Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa
3. Indomethacin for renal impairment in neonatal Bartter's syndrome
4. Rofecoxib
5. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2